L&C BIO Co.,LTD (KOSDAQ: 290650)

L&C BIO Co.,LTD Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	70,031	68,870	52,572	45,677	32,973	29,152
Other Revenue	-	-	-0	-	-	-
Revenue	70,031	68,870	52,572	45,677	32,973	29,152
Revenue Growth (YoY)	3.77%	31.00%	15.10%	38.53%	13.11%	37.24%
Cost of Revenue	36,065	34,100	25,581	17,227	13,414	10,487
Gross Profit	33,966	34,770	26,992	28,450	19,558	18,664
Selling, General & Admin	24,815	20,941	13,941	12,057	9,555	8,023
Research & Development	4,190	3,838	2,195	2,295	2,381	1,346
Operating Expenses	31,541	27,022	17,508	15,280	12,234	9,632
Operating Income	2,425	7,748	9,484	13,170	7,324	9,032
Interest Expense	-6,191	-6,191	-3,076	-460.27	-743.24	-60.55
Interest & Investment Income	1,552	1,552	666.06	431.77	832.3	919.59
Currency Exchange Gain (Loss)	174.35	174.35	-271.63	-58.41	-0.73	3.22
Other Non Operating Income (Expenses)	-623.87	171.32	231.71	302.06	16.38	55.47
EBT Excluding Unusual Items	-2,664	3,454	7,034	13,385	7,429	9,950
Gain (Loss) on Sale of Investments	-863.07	61,740	-2,546	3,667	5,516	-28.32
Gain (Loss) on Sale of Assets	166.43	166.43	75.75	42.98	-	-
Asset Writedown	-2,423	-2,423	-	-	-	-
Pretax Income	-5,783	62,938	4,563	17,095	12,944	9,922
Income Tax Expense	-105.29	14,407	-1,129	1,515	795.51	1,468
Earnings From Continuing Operations	-5,678	48,531	5,692	15,580	12,149	8,454
Minority Interest in Earnings	-283	-170.47	-1,148	-1,766	-1,336	-1,204
Net Income	-5,961	48,361	4,544	13,814	10,813	7,250
Net Income to Common	-5,961	48,361	4,544	13,814	10,813	7,250
Net Income Growth	-	964.24%	-67.11%	27.76%	49.15%	39.22%
Shares Outstanding (Basic)	23	23	23	22	22	22
Shares Outstanding (Diluted)	23	25	23	22	22	22
Shares Change (YoY)	-	8.98%	1.74%	1.83%	-0.33%	14.34%
EPS (Basic)	-262.78	2131.86	200.32	619.55	493.83	331.03
EPS (Diluted)	-262.78	2096.33	200.00	619.55	493.83	330.00
EPS Growth	-	948.17%	-67.72%	25.46%	49.65%	21.70%
Free Cash Flow	-41,993	-36,636	-43,607	655.69	4,403	4,473
Free Cash Flow Per Share	-1851.15	-1481.90	-1922.29	29.41	201.07	203.64
Dividend Per Share	100.000	100.000	-	-	-	-
Gross Margin	48.50%	50.49%	51.34%	62.29%	59.32%	64.02%
Operating Margin	3.46%	11.25%	18.04%	28.83%	22.21%	30.98%
Profit Margin	-8.51%	70.22%	8.64%	30.24%	32.79%	24.87%
Free Cash Flow Margin	-59.96%	-53.20%	-82.95%	1.44%	13.35%	15.35%
EBITDA	9,221	13,402	13,992	16,072	8,911	10,118
EBITDA Margin	13.17%	19.46%	26.61%	35.19%	27.03%	34.71%
D&A For EBITDA	6,795	5,654	4,508	2,902	1,587	1,086
EBIT	2,425	7,748	9,484	13,170	7,324	9,032
EBIT Margin	3.46%	11.25%	18.04%	28.83%	22.21%	30.98%
Effective Tax Rate	-	22.89%	-	8.86%	6.15%	14.79%
Advertising Expenses	-	1,348	723.78	363.15	192.93	264.13

Source: S&P Capital IQ. Standard template. Financial Sources.